Hospital-Acquired Disease Testing Market, By Test Type, By Geography

Description

Hospital-Acquired Disease Testing Market is estimated to be valued at USD 18.6 Bn in 2026 and is expected to reach USD 49.4 Bn by 2033, growing at a compound annual growth rate (CAGR) of 15.5% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 18.6 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	15.50%	2033 Value Projection:	USD 49.4 Bn

Hospital-acquired infections are acquired by the patient under medical care. The most common types of hospital-acquired infections are urinary tract infections, bloodstream infections, Methicillin-resistant Staphylococcus aureus (MRSA), pneumococcal infections, and gastrointestinal illnesses. An increasing rate of morbidity related to hospital-acquired infections worldwide is a major factor driving the growth of the hospital-acquired disease testing market. Devices such as catheters and ventilators that are used in modern care facilities are also among the primary causes of these infections.

Market Dynamics

Key players in the market are focused on adoption of expansion strategies such as mergers and acquisitions, collaborations, and partnerships in order to expand their product portfolio and global presence in the hospital-acquired disease testing market. For instance, in April 2019, Meridian Bioscience, Inc. entered an agreement to acquire GenePOC Inc., a Canada based provider of molecular diagnostic instruments and assays. Through this acquisition, Meridian Bioscience will include state-of-the art revogene molecular diagnostics platform of GenePOC Inc. in its diagnostics portfolio.

Key features of the study

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global hospital-acquired disease testing market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include Luminex Corporation, Diatherix laboratories, Life technologies, Cantel Medical Corporation, Meridian Biosciences Inc, Nordion Inc, Qiagen GmbH, F.Hoffmann-La Roche Ltd., Biomerieux, and Cepheid.
Insights from this report would allow marketers and management authorities of companies to make informed decisions regarding their future product launches, product Type up-gradation, market expansion, and marketing tactics
The global hospital-acquired disease testing market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global hospital-acquired disease testing market

Market Segmentation

By Test Type
- Urinary Tract Infection
- Surgical Site Infection
- Pneumonia Stents
- Blood Stream Infection
- Methicillin-resistant Staphylococcus Aureus (MRSA)
- Others
By Region
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players
- Luminex Corporation
- Diatherix Laboratories
- Life Technologies
- Cantel Medical Corporation
- Meridian Biosciences Inc
- Nordion Inc
- Qiagen GmbH
- Hoffmann-La Roche Ltd.
- Biomerieux
- Cepheid

Product Code: CMI992

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Test Type
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Market Trends
Key Developments
Product Approval
Collaboration/Merge/Acquisition
Regulatory Landscape
PEST Analysis
Porter's Five Forces Analysis
Epidemiology
Robust Pipeline Analysis

4. Global Hospital-Acquired Disease Testing Market, By Test Type, 2026 - 2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026- 2033
- Segment Trends
Urinary Tract Infection
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Bn)
Surgical Site Infection
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Bn)
Pneumonia Stents
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Bn)
Blood Stream Infection
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Bn)
Methicillin-resistant Staphylococcus Aureus (MRSA)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Bn)

5. Global Hospital-Acquired Disease Testing Market, By Region, 2026 - 2033, (USD Bn)

Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2026-2033
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2026 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2026 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (USD Bn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2026 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (USD Bn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2026 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (USD Bn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2026 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (USD Bn)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2026 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2026 - 2033, (USD Bn)
  - North Africa
  - Central Africa
  - South Africa

6. Competitive Landscape

Heat Map Analysis
Market Share Analysis
Company Profile
- Luminex Corporation
Company Highlights
Product Portfolio
Financial Performance
Recent Highlights
Market Strategies
- Diatherix Laboratories
Company Highlights
Product Portfolio
Financial Performance
Recent Highlights
Market Strategies
- Life Technologies
Company Highlights
Product Portfolio
Financial Performance
Recent Highlights
Market Strategies
- Cantel Medical Corporation
Company Highlights
Product Portfolio
Financial Performance
Recent Highlights
Market Strategies
- Meridian Biosciences Inc
Company Highlights
Product Portfolio
Financial Performance
Recent Highlights
Market Strategies
- Nordion Inc
Company Highlights
Product Portfolio
Financial Performance
Recent Highlights
Market Strategies
- Qiagen GmbH
Company Highlights
Product Portfolio
Financial Performance
Recent Highlights
Market Strategies
- F.Hoffmann-La Roche Ltd.
Company Highlights
Product Portfolio
Financial Performance
Recent Highlights
Market Strategies
- Biomerieux
Company Highlights
Product Portfolio
Financial Performance
Recent Highlights
Market Strategies
- Cepheid
Company Highlights
Product Portfolio
Financial Performance
Recent Highlights
Market Strategies
Analyst Views

7. Section

References
Research Methodology
About Us